New & Noteworthy

September 2022

Generic Treatment for Non-Squamous Non-Small Cell Lung Cancer

Fresenius Kabi USA

Fresenius Kabi releases PEMEtrexed for Injection, USP, a generic equivalent to Alimta. Produced in the United States, PEMEtrexed for Injection, USP is designed as an affordable treatment option for adult patients with non-squamous non-small cell lung cancer and malignant pleural mesothelioma. The product is available in four presentations: 100 mg per single dose vial, 500 mg per single dose vial, 750 mg per single dose vial, and 1 gram per single dose vial. This product is included in Fresenius Kabi’s KabiConnect program, part of the KabiCare patient support program offering copay assistance to eligible US patients.

Request More Information

Current Issue